Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Myosin light chain kinase fragment 11-19 amide

SKU: orb1943033

Description

MLCK(11-19) amide is a peptide inhibitor that specifically targets myosin light chain kinase, blocking its activity and inhibiting Ca2+ influx triggered by hypotonic stress. It is utilized in biochemical assays and cellular research, including studies on cervical cancer cell lines, to investigate calcium signaling and cytoskeletal regulation.

Research Area

Immunology & Inflammation; Musculoskeletal & Connective Tissue Research

Images & Validation

Key Properties

CAS Number119386-39-9
MW987.16
FormulaC40H78N18O11
SMILES[C@@H](NC([C@@H](NC([C@H](CCCCN)N)=O)CCCCN)=O)(C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)CO)=O)[C@@H](C)O)=O)C)=O)CCCNC(=N)N)=O)C)=O)C)=O)CCCNC(=N)N

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Protein Handling and Storage Guide
Protein Handling Guide
View Guide

Myosin light chain kinase fragment 11-19 amide (orb1943033)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet